drugset / Trial / NCT06409546

Impact of Topical Pentoxifylline and Tocopherol in Treatment and Prevention of Medically-related Osteonecrosis of the Jaws

NCT06409546

Completed 48 enrolled University of Catania
RandomizedParallel-groupDouble-blindTreatment

Summary

While there is no doubt about the benefits of antiresorptives, it is known that patients using these drugs are at increased risk of developing osteonecrosis of the jaws (MRNOJ), especially after oral procedures such as tooth extraction. The management of osteonecrosis has remained a controversial topic within the oral and maxillofacial surgery community. The aim of the present study is to analyze the impact of topical pentoxifilline and tocopherol in the prevention and treatment of MRNOJ.

Timeline

Start
2020-04-02
Primary completion
2023-12-17
Completion
2024-01-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin E Other / unclassified 75 % Topical
Comparator pentoxifilline Unknown 5 % Topical